Success Stories: EB-1A Approved for Postdoctoral Research Associate in Nebraska in the Field of Biomaterials Research
Client’s Testimonial:
Thank you for the notice, That is really good news. [...] I really want to thank your group. In this application, I did less paper work and had more convenience than my colleagues with other attorneys. Especially, recommanders’ letters and petition letter were drafted very quickly. I appreciated for your effective works.
On May 5th, 2015, We Received Another EB1-A (Alien of Extraordinary Ability) Approval for a Postdoctoral Research Associate in the Field of Biomaterials Research (Approval Notice)
Position at the Time of Case Filing: Postdoctoral Research Associate
Country of Origin: China
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: Nebraska
Approval Notice Date: May 5th, 2015
Processing Time: 4 months, 19 days
In this case, the client that we had the opportunity to work with was a Postdoctoral Research Associate from China in the field of Biomaterials Research. He had conducted his research in the highly specialized area of drug delivery. His work had resulted in 25 peer-reviewed scientific articles and numerous presentations at national and international conferences; at the time that his case was filed, his publications had been cited at least 522 times by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of his work. He had also reviewed 20 manuscripts for distinctive, internationally-circulated journals. His superior level of expertise was confirmed in the following quote from an independent recommender, “[Client] is an irreplaceable asset to the scientific and medical communities, and his work is continuing to change the face of biomedical research internationally.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought to remain in the United States to continue work in the area of Biomaterials Research, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in 4 months and 19 days.